Cancers | Top 10 Cited Papers in 2023 in the Section “Cancer Therapy”

We are pleased to invite you to read the top 10 cited papers in 2023 from the Section “Cancer Therapy” in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field.

The list of papers is as follows:

“The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited”
by Kevin Dzobo, Dimakatso A. Senthebane and Collet Dandara
Cancers 2023, 15(2), 376; https://doi.org/10.3390/cancers15020376
Available online: https://www.mdpi.com/2072-6694/15/2/376

“Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches”
by Philip Posdzich, Christopher Darr, Thomas Hilser, Milan Wahl, Ken Herrmann, Boris Hadaschik and Viktor Grünwald
Cancers 2023, 15(2), 461; https://doi.org/10.3390/cancers15020461
Available online: https://www.mdpi.com/2072-6694/15/2/461

“Mechanisms of Acquired Resistance and Tolerance to EGFR Targeted Therapy in Non-Small Cell Lung Cancer”
by Houssein Chhouri, David Alexandre and Luca Grumolato
Cancers 2023, 15(2), 504; https://doi.org/10.3390/cancers15020504
Available online: http://www.mdpi.com/2072-6694/15/2/504

“Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer”
by Vivek P. Chavda, Lakshmi Vineela Nalla, Pankti Balar, Rajashri Bezbaruah, Vasso Apostolopoulos, Rajeev K. Singla, Avinash Khadela, Lalitkumar Vora and Vladimir N. Uversky
Cancers 2023, 15(4), 1023; https://doi.org/10.3390/cancers15041023
Available online: https://www.mdpi.com/2072-6694/15/4/1023

“Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)”
by Maggie Banys-Paluchowski, Thorsten Kühn, Yazan Masannat, Isabel Rubio, Jana de Boniface, Nina Ditsch, Güldeniz Karadeniz Cakmak, Andreas Karakatsanis, Rajiv Dave, Markus Hahn et al.
Cancers 2023, 15(4), 1173; https://doi.org/10.3390/cancers15041173
Available online: https://www.mdpi.com/2072-6694/15/4/1173

“Next Generation BTK Inhibitors in CLL: Evolving Challenges and New Opportunities”
by Anna Maria Frustaci, Marina Deodato, Giulia Zamprogna, Roberto Cairoli, Marco Montillo and Alessandra Tedeschi
Cancers 2023, 15(5), 1504; https://doi.org/10.3390/cancers15051504
Available online: http://www.mdpi.com/2072-6694/15/5/1504

“Discovering the Clinical and Prognostic Role of Pan-Immune-Inflammation Values on Oral Cavity Squamous Cell Carcinoma”
by Chia-Chi Yeh, Huang-Kai Kao, Yenlin Huang, Tsung-You Tsai, Chi-Kuang Young, Shao-Yu Hung, Chuieng-Yi Lu and Kai-Ping Chang
Cancers 2023, 15(1), 322; https://doi.org/10.3390/cancers15010322
Available online: http://www.mdpi.com/2072-6694/15/1/322

“Systematic Review on CAR-T Cell Clinical Trials Up to 2022: Academic Center Input”
by Valentine Wang, Mélanie Gauthier, Véronique Decot, Loïc Reppel and Danièle Bensoussan
Cancers 2023, 15(4), 1003; https://doi.org/10.3390/cancers15041003
Available online: http://www.mdpi.com/2072-6694/15/4/1003

“From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy”
by Peter Vaupel, Helmut Piazena, Markus Notter, Andreas R. Thomsen, Anca-L. Grosu, Felix Scholkmann, Alan Graham Pockley and Gabriele Multhoff
Cancers 2023, 15(5), 1394; https://doi.org/10.3390/cancers15051394
Available online: http://www.mdpi.com/2072-6694/15/5/1394

“Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer”
by Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies and Rajesh Singh
Cancers 2023, 15(4), 1320; https://doi.org/10.3390/cancers15041320
Available online: http://www.mdpi.com/2072-6694/15/4/1320

You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers. If you have any questions, you can contact the Editorial Office at cancers@mdpi.com.

Cancers Editorial Office